Ildong Pharmaceutical Co., Ltd. (KRX:249420)
South Korea · Delayed Price · Currency is KRW
27,100
-300 (-1.09%)
Apr 29, 2026, 9:50 AM KST
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 566.93B | 614.94B | 600.76B | 637.71B | 560.13B | | | | | |
| -7.81% | 2.36% | -5.80% | 13.85% | -0.30% | | | | | |
| 566.93B | 614.94B | 600.76B | 637.71B | 560.13B | | | | | |
| -7.81% | 2.36% | -5.80% | 13.85% | -0.30% | | | | | |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 556.33B | 605.43B | 590.69B | 623.12B | 547.49B | | | | | |
| -8.11% | 2.50% | -5.20% | 13.81% | 0.40% | | | | | |
| 4.14B | 2.24B | 3.77B | 8.86B | 3.41B | | | | | |
| 84.51% | -40.57% | -57.42% | 159.69% | -23.00% | | | | | |
| 2.87B | 3.52B | 3.01B | - | - | | | | | |
| -18.49% | 16.93% | - | - | - | | | | | |
| 3.60B | 3.74B | 3.28B | 5.05B | 4.48B | | | | | |
| -3.91% | 14.11% | -35.07% | 12.88% | -9.42% | | | | | |
| - | - | - | 677.34M | 4.75B | | | | | |
| - | - | - | -85.75% | -33.74% | | | | | |
| 566.93B | 614.94B | 600.76B | 637.71B | 560.13B | | | | | |
| -7.81% | 2.36% | -5.80% | 13.85% | -0.30% | | | | | |
Source: S&P Global Market Intelligence.